Pacira Pharm Inc
(PCRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Sales | 47,165 | 36,662 | 33,564 | 23,259 | 17,141 |
| Cost of Goods | 19,954 | 18,127 | 18,376 | 14,791 | 10,214 |
| Gross Profit | 27,211 | 18,535 | 15,188 | 8,468 | 6,927 |
| Operating Expenses | 31,007 | 27,920 | 25,384 | 22,073 | 19,151 |
| Operating Income | -2,842 | -9,258 | -9,820 | -12,814 | -12,010 |
| Interest Expense | 2,079 | 2,107 | 1,928 | 1,892 | 1,914 |
| Other Income | -116 | -112 | -208 | -78 | -107 |
| Pre-tax Income | -5,037 | -11,477 | -11,956 | -14,784 | -14,031 |
| Net Income Continuous | -5,037 | -11,477 | -11,956 | -14,784 | -14,031 |
| Net Income | $-5,037 | $-11,477 | $-11,956 | $-14,784 | $-14,031 |
| EPS Basic Total Ops | -0.14 | -0.34 | -0.36 | -0.44 | -0.42 |
| EPS Basic Continuous Ops | -0.14 | -0.34 | -0.35 | -0.44 | -0.42 |
| EPS Diluted Total Ops | -0.14 | -0.34 | -0.36 | -0.44 | -0.42 |
| EPS Diluted Continuous Ops | -0.14 | -0.34 | -0.35 | -0.44 | -0.42 |
| EBITDA(a) | $646 | $-5,498 | $-6,963 | $-10,329 | $-9,567 |